mifepristone has been researched along with Affective Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbero, JD; Bioque, M; Cobo, J; García-Rizo, C; González-Rodríguez, A; Huerta-Ramos, E; Labad, J; Monreal, JA; Soria, V; Tost, M; Usall, J | 1 |
Davies, H; Fang, M; Hu, Z; Sun, Y | 1 |
Baier, H; Ingraham, HA; Meijsing, SH; Muto, A; Schaaf, MJ; Schoonheim, PJ; Strasser, D; Yamamoto, KR; Ziv, L | 1 |
Creinin, MD; Hanusa, BH; Rothschild, AJ; Sit, D; Wisner, KL | 1 |
Barber, DJ; Griffiths, MR; Haynes, LE; Hyde, RE; Mitchell, IJ | 1 |
2 review(s) available for mifepristone and Affective Disorders
Article | Year |
---|---|
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
Topics: Affective Disorders, Psychotic; Bipolar Disorder; Cognition Disorders; Cognitive Dysfunction; Depressive Disorder, Major; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mood Disorders; Pituitary-Adrenal System; Pregnenolone; Raloxifene Hydrochloride; Schizophrenia | 2018 |
Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.
Topics: Abortifacient Agents, Steroidal; Antidepressive Agents; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Cushing Syndrome; Endometriosis; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Leiomyoma; Male; Mifepristone; Mood Disorders; Receptors, Glucocorticoid; Receptors, Progesterone | 2014 |
3 other study(ies) available for mifepristone and Affective Disorders
Article | Year |
---|---|
An affective disorder in zebrafish with mutation of the glucocorticoid receptor.
Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Anti-Anxiety Agents; Arginine; Brain; Cell Line, Transformed; Chlorocebus aethiops; Corticotropin-Releasing Hormone; Cysteine; Diazepam; Disease Models, Animal; Escape Reaction; Exploratory Behavior; Fluoxetine; Freezing Reaction, Cataleptic; Hormone Antagonists; Humans; Hydrocortisone; Interpersonal Relations; Mifepristone; Mood Disorders; Mutation; Psychomotor Agitation; Radioimmunoassay; Receptors, Glucocorticoid; Serotonin; Transfection; Zebrafish | 2013 |
Psychiatric outcomes following medical and surgical abortion.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Antidepressive Agents; Depression; Female; Humans; Hydrocortisone; Mifepristone; Mood Disorders; Pregnancy; Saliva; Vacuum Curettage | 2007 |
Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders.
Topics: Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Apoptosis; Avian Proteins; Basigin; Behavior, Animal; Blood Proteins; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Hippocampus; Hormone Antagonists; Immunohistochemistry; Male; Membrane Glycoproteins; Microtubule-Associated Proteins; Mifepristone; Mood Disorders; Neostriatum; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Septal Nuclei | 2001 |